WVE Q4 2022 Earnings — Wave Life Sciences Ltd. Revenue & Financial Results | Market Cap Arena

WVEWave Life Sciences Ltd.

$3B

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M-29.8% YoY

Gross Profit

-$30M-2408.3% margin

Operating Income

-$44M-3516.0% margin

Net Income

-$44M-3527.8% margin

EPS (Diluted)

$-0.47

QoQ Revenue Growth

+334.7%

Cash Flow

Operating Cash Flow

-$33M

Free Cash Flow

-$34M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$146M

Total Liabilities

$191M

Stockholders' Equity

-$45M

Cash & Equivalents

$88M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$2M	-29.8%
Gross Profit	-$30M	-$24M	-24.3%
Operating Income	-$44M	-$36M	-20.6%
Net Income	-$44M	-$35M	-25.7%